share_log

T2 Biosystems | PRE 14A: Preliminary proxy statements relating to merger or acquisition

T2 Biosystems | PRE 14A: Preliminary proxy statements relating to merger or acquisition

T2 Biosystems | PRE 14A：并购重组委托声明
美股SEC公告 ·  2024/11/09 06:05

Moomoo AI 已提取核心信息

T2 Biosystems, Inc. (TTOO.US), a leader in the development of innovative medical diagnostic equipment, has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held on December 30, 2024. The meeting will be conducted solely via live webcast, allowing stockholders to participate, vote, and submit questions online. The company has outlined several key proposals for the meeting, including the election of three directors, Laura Adams, Robin Toft, and Seymour Liebman, to serve until the 2027 annual meeting, the approval of the amendment and restatement of the 2014 Incentive Award Plan, and the ratification of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is leveraging SEC rules that permit proxy materials to be furnished over the Internet, reducing environmental impact and printing costs. Stockholders of record as of November 5, 2024, are entitled to vote at the meeting. The company has emphasized the importance of stockholder votes, urging participation in the meeting or prompt voting by proxy.
T2 Biosystems, Inc. (TTOO.US), a leader in the development of innovative medical diagnostic equipment, has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held on December 30, 2024. The meeting will be conducted solely via live webcast, allowing stockholders to participate, vote, and submit questions online. The company has outlined several key proposals for the meeting, including the election of three directors, Laura Adams, Robin Toft, and Seymour Liebman, to serve until the 2027 annual meeting, the approval of the amendment and restatement of the 2014 Incentive Award Plan, and the ratification of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is leveraging SEC rules that permit proxy materials to be furnished over the Internet, reducing environmental impact and printing costs. Stockholders of record as of November 5, 2024, are entitled to vote at the meeting. The company has emphasized the importance of stockholder votes, urging participation in the meeting or prompt voting by proxy.
T2 Biosystems, Inc. (TTOO.US), 作为创新医疗诊断设备开发领域的领导者，宣布其2024年股东年会将于2024年12月30日举行。 该会议将仅通过现场网络直播进行，允许股东在线参与、投票和提交问题。 该公司已经为会议列出了几项关键议案，包括选举三位董事Laura Adams、Robin Toft和Seymour Liebman，任期直至2027年年会，批准修订2014年激励奖计划，以及批准BDO美国注册会计师事务所作为截至2024年12月31日财年的独立注册公共会计师事务所。 该公司正在利用SEC规定，允许通过互联网提供代理材料，降低环境影响和印刷成本。 截至2024年11月5日持股的股东有权在会议上投票。 该公司强调了股东投票的重要性，敦促参与会议或及时通过代理投票。
T2 Biosystems, Inc. (TTOO.US), 作为创新医疗诊断设备开发领域的领导者，宣布其2024年股东年会将于2024年12月30日举行。 该会议将仅通过现场网络直播进行，允许股东在线参与、投票和提交问题。 该公司已经为会议列出了几项关键议案，包括选举三位董事Laura Adams、Robin Toft和Seymour Liebman，任期直至2027年年会，批准修订2014年激励奖计划，以及批准BDO美国注册会计师事务所作为截至2024年12月31日财年的独立注册公共会计师事务所。 该公司正在利用SEC规定，允许通过互联网提供代理材料，降低环境影响和印刷成本。 截至2024年11月5日持股的股东有权在会议上投票。 该公司强调了股东投票的重要性，敦促参与会议或及时通过代理投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    特斯拉
    TSLA
    -- 355.840
    英伟达
    NVDA
    -- 138.850
    阿里巴巴
    BABA
    -- 124.730
    英特尔
    INTC
    -- 23.600
    Tempus AI
    TEM
    -- 89.440
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球市场会如何演变？
    🎙️讨论： 1. 关税政策将如何影响美股、黄金、比特币等核心资产的走势？ 2. 在此背景下，有哪些投资机会值得关注？你会如何布局？ 展开
    MicroStrategy 2024年第四季度业绩电话会
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。